A 45-year-old male agricultural worker from Sudan presents with a 5-year history of painless, progressive swelling of the left foot with multiple discharging sinuses. Examination reveals a woody-hard subcutaneous mass with purulent discharge containing black grains. KOH mount of the discharge shows broad, septate fungal hyphae. The diagnosis of eumycetoma (Madurella mycetomatis) is confirmed. Which of the following represents the MOST APPROPRIATE MANAGEMENT APPROACH for this patient, as marked **A** in the diagram?
A. Empirical anti-tuberculous therapy
B. Short-course oral antibiotics for 7 days
C. Topical corticosteroids as first-line
D. Long-term itraconazole (12+ months) plus wide surgical debridement
Explanation
Why Long-term itraconazole (12+ months) plus wide surgical debridement is right
Eumycetoma caused by true fungi (Madurella mycetomatis and related fungi) requires prolonged antifungal therapy combined with aggressive surgical intervention. Itraconazole 200–400 mg twice daily for 12 or more months is the standard antifungal regimen, and wide local surgical excision or debridement is essential to remove the granulomatous tissue and prevent recurrence. This combined medical-surgical approach reflects the chronic, granulomatous, progressively destructive nature of eumycetoma and is the only strategy with any chance of cure (25–35% cure rates), though recurrences remain common and amputation may be necessary in advanced disease. The black grains in the discharge are pathognomonic for Madurella and confirm fungal etiology, mandating antifungal therapy rather than antibiotics.
Why each distractor is wrong
Short-course oral antibiotics for 7 days: Eumycetoma is a fungal infection, not bacterial. Antibiotics are ineffective against true fungi. This regimen is appropriate for actinomycetoma (caused by aerobic filamentous bacteria), which responds well to combination antibiotics (Welsh regimen or amoxicillin-clavulanate) for 6–12 months with cure rates >90%, but is entirely inappropriate for eumycetoma.
Topical corticosteroids as first-line: Topical corticosteroids have no role in mycetoma management. They do not treat the underlying fungal infection and may suppress local immune responses, potentially worsening the granulomatous disease. Mycetoma requires systemic antifungal therapy and surgical debridement, not immunosuppression.
Empirical anti-tuberculous therapy: Although mycetoma is a chronic granulomatous infection, it is NOT tuberculosis and does not respond to anti-tuberculous drugs. The diagnosis has been confirmed as eumycetoma by KOH microscopy (broad, septate fungal hyphae) and clinical presentation (black grains). Anti-TB therapy would delay appropriate treatment and allow disease progression.
High-YieldNEET PG
Eumycetoma = fungal → itraconazole 12+ months + wide surgery; Actinomycetoma = bacterial → antibiotics alone (Welsh regimen, 6–12 months); grain color is a diagnostic clue—BLACK = Madurella (eumycetoma).
WHO Mycetoma Programme; Fahal AH. Trans R Soc Trop Med Hyg 2017
Practice similar questions
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.
